Advanced search

Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
De Meyer, SF, K Vanhoorelbeke, H Ulrichts, S Staelens, Hendrik Feys, I Salles, A Fontayne, and H Deckmyn. 2006. “Development of Monoclonal Antibodies That Inhibit Platelet Adhesion or Aggregation as Potential Anti-thrombotic Drugs.” Cardiovascular & Hematological Disorders. Drug Targets 6 (3): 191–207.
APA
De Meyer, SF, Vanhoorelbeke, K., Ulrichts, H., Staelens, S., Feys, H., Salles, I., Fontayne, A., et al. (2006). Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs. CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS, 6(3), 191–207.
Vancouver
1.
De Meyer S, Vanhoorelbeke K, Ulrichts H, Staelens S, Feys H, Salles I, et al. Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs. CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS. 2006;6(3):191–207.
MLA
De Meyer, SF, K Vanhoorelbeke, H Ulrichts, et al. “Development of Monoclonal Antibodies That Inhibit Platelet Adhesion or Aggregation as Potential Anti-thrombotic Drugs.” CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS 6.3 (2006): 191–207. Print.
@article{8549121,
  author       = {De Meyer, SF and Vanhoorelbeke, K and Ulrichts, H and Staelens, S and Feys, Hendrik and Salles, I and Fontayne, A and Deckmyn, H},
  issn         = {1871-529X},
  journal      = {CARDIOVASCULAR \& HEMATOLOGICAL DISORDERS. DRUG TARGETS},
  language     = {eng},
  number       = {3},
  pages        = {191--207},
  title        = {Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs},
  url          = {http://dx.doi.org/10.2174/187152906778249536},
  volume       = {6},
  year         = {2006},
}

Altmetric
View in Altmetric